Navigation Links
Growing nerve cells in 3-D dramatically affects gene expression

When it comes to growing cells in a lab, technique matters. A new Brown University study shows that nerve cells grown in three-dimensional cultures use 1,766 genes differently compared to nerve cells grown in standard two-dimensional petri dishes.

The study, published in the May issue of Tissue Engineering, adds to a growing body of research showing that culture techniques can significantly affect cell growth and function. This research shows that cells grown in a laboratory in 3-D environments, not in flat petri dishes, are more like cells grown in the ultimate 3-D environment ?the human body.

"More and more, we're seeing evidence that cells cultured in three dimensions look and behave more like cells in your body," said Diane Hoffman-Kim, the Brown bioengineer who spearheaded the new study, "so culture method is critical. If you want to better understand how the human body behaves or how new drugs might fight disease, 3-D may be a better bet."

For more than 100 years, scientists have grown human cells in flat dishes. In these 2-D glass incubators, better known as petri dishes, cells stick to the bottom and spread out as they multiply. But in the body, cells don't grow that way. They are suspended in fluids and gels and surrounded by other cells. And these cells aren't stuck; they move.

As a result, some scientists suspect that hothouse cells do not behave like in vivo varieties. This means that the critical functions scientists are trying to understand by studying these cells ?from the proliferation of cancer to the bacterial assault by antibiotics ?may play out differently. Studies indeed show differences in behavior between cells cultured in 2-D and in 3-D. Cells cultured in 3-D, for example, grow faster.

Hoffman-Kim, an assistant professor of medical science and engineering at Brown, wants to find a way to repair damaged nerve tissue. To get there, she needs to grow nerve cells that will flourish when plac ed inside the body. So Hoffman-Kim put 2-D and 3-D cell culture methods to a comparative test. Would the cells be different" Which ones would grow best"

To answer that question, Hoffman-Kim and researchers in her lab took a line of cancerous nerve cells and cultured them in different environments. They placed one batch of cells in standard petri dishes coated with collagen. They suspended the other batch in a thicker collagen gel. The bioengineers took great pains to be sure that this one-dimension difference was the only difference in the culture conditions. Team members even counted individuals cells as they went into the dishes to be sure that each dish contained precisely the same amount.

After a day of growth, the researchers extracted RNA from the cells and conducted a microarray analysis to determine differences in gene activity. The results: A whopping 1,766 genes responded differently, either switching on or switching off. To check their work, researchers repeated the experiments but this time produced multiple copies of eight genes specifically linked to cell growth. Those experiments confirmed the differences in gene activity.

Hoffman-Kim and her team deployed high-powered microscopes to detect other differences. Cells cultured in 3-D had a rounder, more realistic shape, and their neurites ?spindly projections sprouting from the cell body ?were longer.

"The cells in 3-D culture grew faster and looked more like the body's cells," she said. "This means that this culture method might create tissue that could be more successfully implanted."


'"/>

Source:Brown University


Related biology news :

1. Growing crops to cope with climate change
2. Wisconsin scientists grow critical nerve cells
3. Clam embryo study shows pollutant mixture adversely affects nerve cell development
4. Zebrafish may hold key to understanding human nerve cell development
5. New component of the brakes on nerve regeneration found
6. Cerebral navigation: How do nerve fibers know what direction to grow in?
7. Molecular messengers perform a crucial role in the ability of injured nerve cells to heal themselves
8. Diabetic nerve therapy shows striking results
9. Malfunctioning bone marrow cells sabotage nerve cells in diabetes
10. UIC researchers show protein routes messages in nerve cells
11. Researchers find molecule that inhibits regrowth of spinal nerve cells
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology: